Navigation Links
PixCell IIe LCM Instrument with PixCell II Image Archiving Workstation (110 volts) from Arcturus, now part of Molecular Devices

ProductsPixCell IIe LCM Instrument with PixCell II Image Archiving Workstation (110 volts) from Arcturus, now part of Molecular Devices
Company Arcturus, now part of Molecular Devices
Item PixCell IIe LCM Instrument with PixCell II Image Archiving Workstation (110 volts)
Price 
Description Obtain Clean and Accurate Results

Laser Capture Microdissection (LCM) enables you to dramatically increase the sensitivity and accuracy of molecular assays by starting with samples of homogeneous cell types and multi-cellular structures isolated from whole tissue or cytology samples. This unique approach to microdissection-developed in 1996 at the National Institutes of Health and available exclusively from Arcturus-ensures that biological molecules such as RNA and DNA, remain undamaged during the microdissection process. Downstream molecular analysis of these molecules produces accurate and assured results that have led to over 300 peer-reviewed publications by independent researchers.

Use with All Fixed Tissue and Cell Preparations

LCM has enormous flexibility with respect to tissue and cell fixation preparations. LCM effectively extracts cells from both paraffin-embedded and frozen tissue sections prepared using a wide variety of different dyes, slide surfaces, and protocols.

Isolate Cells of Interest Quickly and Conveniently

LCM utilizes a low-power infrared laser to melt a special thermoplastic film over the cell(s) of interest. Especially developed CapSure HS or CapSure Macro Caps that are coated with this thermoplastic film are placed on the tissue section or cytology sample. The PixCell IIe LCM instrument is then used to direct the laser through the cap to melt the film onto the cells of interest. When you lift the cap, the selected cells remain attached and are captured for further analysis.

Info Arcturus, now part of Molecular DevicesArcturus, now part of Molecular Devices
400 Logue Avenue
Mountain View, CA 94043, USA
Customer Service: 650.962.3020
Fax Number: 650.962.3039
Web Site: http://www.arctur.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. PixCell IIe LCM Instrument with PixCell II Image Archiving Workstation (220 volts) from Arcturus, now part of Molecular Devices
2. Full-Configuration Camera Link NI PCIe-1429 from National Instruments Corporation
3. Bio-Stack Twister II Microplate Handler from BioTek Instruments
4. ELx50 Microplate Strip Washer from BioTek Instruments
5. Bio-Stack Microplate Stacker from BioTek Instruments
6. DMWB3-223ASC Digital Compound DIN from Motic Instruments, Inc.
7. DMWB1-223ASC Digital Compoud DIN from Motic Instruments, Inc.
8. Precision XS Microplate Sample Processor from BioTek Instruments
9. Synergy HT Multi-Detection Microplate Reader from BioTek Instruments
10. RapidCycler 2 Instrument from Idaho Technology Inc.
11. DMW-143 FBGG Digital Stereo Zoom from Motic Instruments, Inc.
... a compact benchtop and stackable multi-function ... with a large display screen to ... Air circulation inside to evenly distribute ... be easily calibrated from the microprocessor ...
... siTrio siRNA --- a cocktail of ... gene of interestis our most popular product. ... than 75% knockdown of your target gene ... siRNA for transfection and confirmation of optimal ...
... siTrio siRNA --- a cocktail of ... gene of interestis our most popular product. ... than 75% knockdown of your target gene ... siRNA for transfection and confirmation of optimal ...
...
Biology Products:
(Date:3/24/2015)... 24, 2015   NexID Biometrics LLC, whose ... needs, today announced the beginning of shipments of version ... The company, based in Potsdam, N.Y. ... Connect:ID Expo, which began here today at the Walter ... 2.0 of its SDK boosts the accuracy rate range ...
(Date:3/23/2015)...   HOYOS Labs , a leading global authentication ... the Company will demonstrate multiple biometrics-based technologies under its ... Connect:ID on March 23 through 25, 2015, in ... the IEEE Biometric Open Protocol Standard; free biometrics-based consumer ... control system. BOPS was invented by HOYOS Labs and ...
(Date:3/20/2015)... DUBLIN , Mar. 20, 2015 Research ... announced the addition of the "India Sensors ... their offering. The sensor market is ... through 2020 Consumer electronics, automotive, industrial ... for sensors in the country. In addition, adoption ...
Breaking Biology News(10 mins):NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 3
... Earth,s history has been going on for hundreds of millions of ... existed, scientists reported today in the journal Nature . ... organism in the oceans, survives where most other cells would die ... had been theorized that SAR11 was so small and widespread that ...
... University of Alberta study shows that busy beavers are helping Canada ... begin spring nesting. Ponds in Alberta where beavers were active ... geese a better chance at reproductive success, according to the study, ... the first to link beavers to early season nesting habits of ...
... the NSERC Canadian Network for Aquatic Ecosystems (CNAES) will ... made when it comes to this country,s wetlands, lakes ... from the Natural Sciences and Engineering Research Council, in ... organizations, was recently announced as part of the government,s ...
Cached Biology News:A war without end -- with Earth's carbon cycle held in the balance 2Canada's aquatic ecosystems research gets boost from NSERC 2
(Date:4/16/2015)... April 16, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: ... U.S. joint venture with G-treeBNT (ReGenTree LLC) has ... clinical trial for the orphan disorder, neurotrophic keratopathy ... dry eye syndrome (DES) in the U.S.  Both ... RGN-259/GBT201, this year.  Each of these eye disorders ...
(Date:4/16/2015)... (PRWEB) April 16, 2015 A new ... it easier for research institutions to learn how Appleā€™s ... data. , The timing is ideal since Apple made ... Research Kit is an open-source framework for developing medical ... provides a way for researchers to collect secure clinical ...
(Date:4/16/2015)... , April 16, 2015 Avelas Biosciences, an ... improving cancer surgeries, announced today that it has initiated ... illuminator, AVB-620, in women with primary, non-recurrent breast cancer ... also welcomed the addition of Steven Chen , ... The open label, dose escalation study will enroll up ...
(Date:4/16/2015)... VANCOUVER, British Columbia and MENLO ... DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) (DelMar and the ... proven cancer therapies in new orphan drug indications, today ... has been added as a clinical trial site for ... patients with refractory glioblastoma multiforme (GBM), the most common ...
Breaking Biology Technology:RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 3RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 5Infographic Illustrates Potential for Research Kit to Impact Clinical Research 2Infographic Illustrates Potential for Research Kit to Impact Clinical Research 3Avelas Biosciences Initiates Phase 1b Trial of AVB-620 in Breast Cancer Patients 2Avelas Biosciences Initiates Phase 1b Trial of AVB-620 in Breast Cancer Patients 3DelMar Pharmaceuticals Adds Fourth Clinical Trial Site in Phase I/II Multicenter Study of VAL-083 for Recurrent Malignant Glioma 2DelMar Pharmaceuticals Adds Fourth Clinical Trial Site in Phase I/II Multicenter Study of VAL-083 for Recurrent Malignant Glioma 3DelMar Pharmaceuticals Adds Fourth Clinical Trial Site in Phase I/II Multicenter Study of VAL-083 for Recurrent Malignant Glioma 4DelMar Pharmaceuticals Adds Fourth Clinical Trial Site in Phase I/II Multicenter Study of VAL-083 for Recurrent Malignant Glioma 5